incontinent patient News
-
Mera Medical Solutions at the Düsseldorf Medical Fair
MEDICA , the largest international fair in the medical technology sector, will hold a new edition from November 18 to 21, 2019 in Düsseldorf (Germany) . The fair in the 2019 edition will welcome the visit of 120,000 people and will be attended by 5,100 exhibitors presenting their latest products and developments, among which there will be well-known companies, as well as young start-ups ...
-
Bluewind Medical Ltd. Completes OASIS Study Patient Enrollment
Bluewind Medical, Ltd., developer of the innovative RENOVA iStim implantable neuromodulation device for treatment of urinary urgency incontinence, today announced the successful completion of patient enrollment in the OASIS pivotal clinical study that will be the basis by which the company will seek US-FDA (Food & Drug Administration) marketing clearance in the United States. OASIS is a ...
-
Neuspera Announces Second Phase of Sans-UUI IDE Clinical Trial with Nuvella System
Neuspera Medical, a medical device company developing implantable devices for patients battling chronic illnesses, today announced it will begin enrollment in its pivotal clinical trial (SANS-UUI), a single-arm study that will enroll 145 patients at 25 sites globally. The study will evaluate the safety and efficacy of Neuspera’s Nuvella™ system designed to treat overactive bladder ...
-
Neuspera Medical Receives Investigational Device Exemption for Its Ultra-Miniaturized Implantable Device
Neuspera Medical Inc., a clinical stage, private, venture capital backed neuromodulation company, announced the receipt of an Investigational Device Exemption (IDE) from the FDA – enabling the company to conduct the first long-term clinical trial of its ultra-miniaturized neuromodulation platform. An MRI Conditional version of Neuspera’s wirelessly powered implant designed for use as ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you